Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,69 USD | +1,50% | +3,68% | -3,43% |
Omzet 2024 * | 3,4 mln. 3,18 mln. | Omzet 2025 * | 4,28 mln. 4 mln. | Marktkapitalisatie | 7,23 mln. 6,76 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -19 mln. -17,77 mln. | Nettowinst (verlies) 2025 * | -22 mln. -20,58 mln. | EV/omzet 2024 * | 2,13 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 1,69 x |
K/w-verhouding 2024 * |
-0,74
x | K/w-verhouding 2025 * |
-0,9
x | Werknemers | 20 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 96,77% |
Recentste transcriptie over Plus Therapeutics, Inc.
1 dag | +1,50% | ||
1 week | +3,68% | ||
Lopende maand | -6,37% | ||
1 maand | -9,14% | ||
3 maanden | -17,96% | ||
6 maanden | +56,48% | ||
Lopend jaar | -3,43% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Marc Hedrick
CEO | Chief Executive Officer | 61 | 01-10-02 |
Andrew Sims
DFI | Director of Finance/CFO | 51 | 06-02-20 |
Pius Maliakal
CTO | Chief Tech/Sci/R&D Officer | - | 27-07-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Marc Hedrick
CEO | Chief Executive Officer | 61 | 01-10-02 |
Richard Hawkins
CHM | Chairman | 75 | 01-12-07 |
Robert Lenk
BRD | Director/Board Member | 75 | 01-03-20 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 1,69 | +1,50% | 16 331 |
25-04-24 | 1,665 | +4,06% | 5 262 |
24-04-24 | 1,6 | -1,84% | 8 544 |
23-04-24 | 1,63 | -1,81% | 17 177 |
22-04-24 | 1,66 | +1,84% | 199 230 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:30 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,43% | 7,23 mln. | |
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |